Aeterna Zentaris to Announce Second Quarter 2013 Financial and Operating Results on August 8, 2013

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\nMONTREAL, Aug. 1, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") will announce its second quarter 2013\n financial and operating results after market close on Thursday, August\n 8, 2013. The Company will host a conference call to discuss these\n results on Friday, August 9, 2013, at 8:30 a.m., Eastern Time.\n\n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers:\n in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.\n A replay of the webcast will also be available on the Company's website\n for a period of 30 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in\n developing novel treatments in oncology and endocrinology. The\n Company's pipeline encompasses compounds from drug discovery to\n regulatory approval. For more information, visit www.aezsinc.com.\n\n\nSOURCE: Aeterna Zentaris Inc.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] Copyright CNW Group 2013","length":2087,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.